PRELUDE CAPITAL MANAGEMENT, LLC - AMNEAL PHARMACEUTICALS INC ownership

AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 157 filers reported holding AMNEAL PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.77 and the average weighting 0.0%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of AMNEAL PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$24,998
-98.4%
12,562
-96.3%
0.00%
-97.4%
Q4 2020$1,547,000
+45.5%
338,426
+23.5%
0.04%
-23.5%
Q3 2020$1,063,000
+57.5%
273,972
+93.2%
0.05%
+37.8%
Q2 2020$675,000
-10.6%
141,842
-34.6%
0.04%
-27.5%
Q1 2020$755,000
+8288.9%
216,842
+16580.2%
0.05%
Q2 2019$9,000
-59.1%
1,300
-3.1%
0.00%
-100.0%
Q2 2018$22,0001,3410.00%
Other shareholders
AMNEAL PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Fosun International Ltd 21,521,301$102,442,0009.84%
TPG Group Holdings (SBS) Advisors, Inc. 16,213,367$77,176,0001.36%
Sivik Global Healthcare LLC 600,000$2,856,0000.95%
THB ASSET MANAGEMENT 651,150$3,099,0000.90%
Eversept Partners, LP 886,587$4,220,1540.58%
Spark Investment Management LLC 30,100$143,0000.52%
GLOBEFLEX CAPITAL L P 240,680$1,146,0000.29%
Alambic Investment Management, L.P. 19,493$93,0000.23%
GSA CAPITAL PARTNERS LLP 49,901$238,0000.13%
C M BIDWELL & ASSOCIATES LTD 29,550$141,0000.13%
View complete list of AMNEAL PHARMACEUTICALS INC shareholders